Literature DB >> 8578854

Genotypic variation in coxsackievirus B5 isolates from three different outbreaks in the United States.

H Kopecka1, B Brown, M Pallansch.   

Abstract

Genomic sequences in VP1/2A and 5'-non-coding region of 10 isolates of Coxsackievirus B5 from three outbreaks were compared with published sequences of another Coxsackievirus B5, swine vesicular disease virus, Coxsackievirus B1, Coxsackievirus B3, and Coxsackievirus B4. Isolates of Coxsackievirus B5 from the same outbreak showed close relations, not exceeding 7.2% in nucleotide differences. Differences were greater between isolates from different outbreaks, varying between 8.4 and 16%. We have also shown that Coxsackie B5 viruses from an outbreak in 1967 are more similar to viruses from an outbreak in 1983 than to the viruses isolated from an intervening outbreak in 1972. The sequence comparison of Coxsackievirus B5 isolates with other Coxsackie B viruses and swine vesicular study, cDNA synthesis, polymerase chain reaction, and sequencing, are suitable for rapid Coxsackie B virus detection and identification of genotypic relations between viruses originating from different outbreaks.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578854     DOI: 10.1016/0168-1702(95)00055-u

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  20 in total

1.  Molecular identification of enterovirus by analyzing a partial VP1 genomic region with different methods.

Authors:  G Palacios; I Casas; A Tenorio; C Freire
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

2.  Genomic variations in echovirus 30 persistent isolates recovered from a chronically infected immunodeficient child and comparison with the reference strain.

Authors:  J L Bailly; M Chambon; C Henquell; J Icart; H Peigue-Lafeuille
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Typing of human enteroviruses by partial sequencing of VP1.

Authors:  M S Oberste; K Maher; D R Kilpatrick; M R Flemister; B A Brown; M A Pallansch
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

4.  Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification.

Authors:  M S Oberste; K Maher; D R Kilpatrick; M A Pallansch
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

Review 5.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Detection and analysis of a small round-structured virus strain in oysters implicated in an outbreak of acute gastroenteritis.

Authors:  F Le Guyader; F H Neill; M K Estes; S S Monroe; T Ando; R L Atmar
Journal:  Appl Environ Microbiol       Date:  1996-11       Impact factor: 4.792

7.  Molecular phylogeny and proposed classification of the simian picornaviruses.

Authors:  M Steven Oberste; Kaija Maher; Mark A Pallansch
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

8.  Type-specific detection of echovirus 30 isolates using degenerate reverse transcriptase PCR primers.

Authors:  D R Kilpatrick; J Quay; M A Pallansch; M S Oberste
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

9.  Recombination in circulating enteroviruses.

Authors:  Alexander N Lukashev; Vasilii A Lashkevich; Olga E Ivanova; Galina A Koroleva; Ari E Hinkkanen; Jorma Ilonen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Prospective identification of enteroviruses involved in meningitis in 2006 through direct genotyping in cerebrospinal fluid.

Authors:  Audrey Mirand; Cécile Henquell; Christine Archimbaud; Martine Chambon; Françoise Charbonne; Hélène Peigue-Lafeuille; Jean-Luc Bailly
Journal:  J Clin Microbiol       Date:  2007-10-31       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.